Ventyx Biosciences, Inc. (NASDAQ:VTYX) filed a Form 8-K with the Securities and Exchange Commission on January 22, 2026, disclosing a material event.
Ventyx Biosciences, Inc.'s stock currently trades at $13.92 with a market capitalization of $607.6M. The Healthcare company's stock moved following the disclosure.